MASSBIOME Partnership Program

Grow your microbiome services with MASSBIOME.

From white-label microbiome products to laboratory reporting, API integration, distribution and research collaborations — let's find the partnership model that fits your business, together.

Full-Length 16S rDNA Oxford Nanopore long-read sequencing covering the V1–V9 regions (~1500 bp) for species-level microbiome profiling.
In-House Workflow On-premises processing: your samples, your data and your revenue stay inside your organisation.
White-Label Ready MASSBIOME-branded, co-branded or white-label reports, with technical, scientific and commercial support.
Choose your model

One platform. Multiple ways to partner.

Whether you want to launch your own branded test, integrate MASSBIOME into your digital ecosystem, add microbiome reporting to your laboratory, distribute the solution in your territory, support your patients or run a research project, we'll shape the collaboration around your needs.

01

White-Label Partner — Own Brand

Discover now →

Launch a microbiome analysis product under your own brand, powered by MASSBIOME technology, analysis and reporting infrastructure.

A tailor-made white-label solution, flexible branding and individual commercial terms.
02

White-Label Partner — API Integration

Discover now →

Offer microbiome analysis inside your own application, portal or healthcare ecosystem through API-based integration with MASSBIOME.

Tailor-made technical integration, a branded customer experience and direct support from our software and bioinformatics teams.
03

Laboratory Partner

Discover now →

Run gut microbiome analysis in-house. Sequence with Oxford Nanopore technology and get automated analysis and structured reports for your laboratory or your clients.

Reports carrying your branding, an automated bioinformatics pipeline and a scalable workflow without building an internal analysis team.
04

Distributor / Reseller

Discover now →

Bring MASSBIOME into your market through your established laboratory, healthcare or life-science distribution network.

Individual dealer terms, commercial onboarding, product training and official marketing materials provided by Massive Bioinformatics.
05

Healthcare Professional

Discover now →

Offer gut microbiome analysis to your patients through your clinic, practice or nutrition service, without setting up a laboratory workflow yourself.

Clear, clinician-friendly reports that support your clinical decision-making, flexible ordering models and scientific support from our team.
06

Research

Discover now →

You are planning a microbiome study and need sequencing, taxonomic analysis, functional evaluation or scientific expertise for your research project.

Full-length 16S rDNA sequencing and bioinformatics services with taxonomic and functional analysis, custom outputs and expert scientific support.
Why MASSBIOME

A partnership built around more than software.

MASSBIOME brings together long-read microbiome sequencing, automated bioinformatics, structured reporting, laboratory workflow know-how and dedicated support from Massive Bioinformatics — in one B2B platform.

✓
Full-length 16S rDNA workflow
Oxford Nanopore long-read sequencing (V1–V9, ~1500 bp) designed for species-level microbiome profiling.
✓
Flexible branding
MASSBIOME-branded, co-branded or white-label models — with brand guidelines and approved materials to keep every touchpoint consistent.
✓
Training & scientific support
Wet lab, sequencing, bioinformatics, reporting and marketing training from one team.
✓
Scalable collaboration
Suitable for individual clinics, laboratories, distributors and multi-site partners.

Which partnership model fits your business?

Tell us how you'd like to work with microbiome analysis, and our team will help you define the most suitable technical and commercial model.

Schedule a Meeting

Disclaimer
MASSBIOME is a Clinical Decision Support Software (CDSS) providing microbiome composition analysis for clinical decision support. Results are intended for use by qualified healthcare professionals as part of their overall patient assessment. MASSBIOME does not provide medical diagnoses or treatment recommendations and is not intended to diagnose, treat, cure or prevent any disease. MASSBIOME is a trademark of Massive Bioinformatics ARGE Teknolojileri A.Ş.